Rare diseases
Investigational molecules
Locations
293 conditions with trials, the busiest first
1 664 trials across Europe, recruiting first
Study on the Effectiveness of PQ Grass for Children and Teens with Seasonal Allergies from Grass Pollen
BulgariaStudy on the Effectiveness and Safety of Deucravacitinib for Adults with Active Sjogren's Syndrome
AustriaA Study of Baricitinib to Preserve Beta Cell Function in Children and Adults Newly Diagnosed With Type 1 Diabetes
BelgiumA Study of Baricitinib to Delay Type 1 Diabetes in Children and Adults at Risk of Developing the Disease
BelgiumA Study of ANX005 for Patients Recently Diagnosed with Guillain-Barré Syndrome to Evaluate How the Drug Works in the Body and Its Safety
DenmarkPhase III trial evaluating ianalumab with background drug combination in patients with Sjögren's disease
AustriaEfficacy of Tree SLIT-tablet and Betula pendula pollen extract in adolescents (12‑17) with allergic rhinitis/rhinoconjunctivitis caused by birch pollen
FranceA Phase 2/3 Randomized Double‑Blind Study of Inebilizumab for Safety and Tolerability in Patients with Autoimmune Hepatitis
BelgiumStudy of Beclometasone Dipropionate in Patients with Asthma to Evaluate Disease Characteristics and Control
FrancePharmacokinetics, Safety and Efficacy of Nemolizumab in Infants 6–23 Months with Moderate-to-Severe Atopic Dermatitis
PolandStudy of belumosudil versus drug combination in patients aged 12 years and older with chronic graft‑versus‑host disease refractory after prior therapy
AustriaSafety and efficacy of oral ACT-777991 in adults with non‑segmental vitiligo: a randomized, double‑blind, placebo‑controlled Phase 2a trial
CzechiaThe therapies tested most often in Immune system disorders trials.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
